Which hedge funds own JBIO? JADE BIOSCIENCES INC, Q2 2026 13F holders
37 tracked hedge funds disclosed a position in JBIO (JADE BIOSCIENCES INC) in their Q2 2026 13F filings, worth $650.0m in total. The largest holder by portfolio weight is Fairmount Funds Management LLC at 6.7% of its book. 16 opened a new position this quarter: Verdad Advisers, LP, Paradigm Biocapital Advisors LP, Polar Capital Holdings Plc, Seven Grand Managers, LLC. 9 exited: Great Point Partners LLC, Stempoint Capital LP, RTW Investments, LP.
- 37
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 16
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 9
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $166m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $27.8m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $650m
- Combined value Sum of the holders' reported positions in the security.
- 3.0%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Great Point Partners LLC | 3.3% | $13.6m |
| Stempoint Capital LP | 0.4% | $2.2m |
| RTW Investments, LP | 0.08% | $8.1m |
| Orbimed Advisors LLC | 0.06% | $2.6m |
| Gsa Capital Partners LLP | 0.02% | $275k |
| ADAR1 Capital Management, LLC | 0.02% | $281k |
| Y-Intercept (Hong Kong) Ltd | 0.01% | $353k |
| ExodusPoint Capital Management, LP | 0.0% | $199k |
| Qube Research & Technologies Ltd | 0.0% | $348k |
Ownership over time
Who discovered JBIO first? Beta
| Fairmount Funds Management LLC high conviction | Q2 2025 | +3.6 pts |
| Avidity Partners Management LP high conviction | Q4 2025 | +3.2 pts |
| Venrock Adviser, LLC | Q2 2025 | +1.7 pts |
| Great Point Partners LLC | Q2 2025 | +1.0 pts |
| Ikarian Capital, LLC | Q1 2026 | +0.5 pts |
| Logos Global Management LP | Q2 2025 | +0.4 pts |
| Soleus Capital Management, L.P. | Q2 2026 | +0.4 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.